当前位置：药药网 / 数据中心 /靶点针对疾病信息(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息13(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
Farnesoid X-activated receptor (FXR)
INDICATI
Approved Autoimmune liver disease [ICD-11: DB96]
INDICATI
Approved Cholelithiasis [ICD-11: DC11]
INDICATI
Approved Insomnia [ICD-11: 7A00-7A0Z]
INDICATI
Phase 3 Breast cancer [ICD-11: 2C60-2C6Y]
INDICATI
Phase 2 Skeletal anomaly [ICD-11: LD24]
INDICATI
Phase 1 Hepatic fibrosis/cirrhosis [ICD-11: DB93]
INDICATI
Phase 1 Hyper-lipoproteinaemia [ICD-11: 5C80]
INDICATI
Discontinued in Phase 2 Type 2 diabetes mellitus [ICD-11: 5A11]